Nicolas Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicolas Kumar has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Amit Bardia
10 shared publicationsAdam A. Dalia
5 shared publicationsJamel P. Ortoleva
5 shared publicationsManoj H. Iyer
Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio
5 shared publicationsTamara R. Sawyer
5 shared publicationsMichael Essandoh
Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio
4 shared publications
Latest Publications
- 27 July 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (14) , 1972-1974
Variation in Nationwide Antibiotic Practices in Patients Undergoing Transcatheter Aortic Valve Replacement
- 27 July 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (14) , 1972-1974
Variation in Nationwide Antibiotic Practices in Patients Undergoing Transcatheter Aortic Valve Replacement
- 13 July 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (11) , 3638-3647
Vasoplegic Syndrome during Left Ventricular Assist Device Insertion: A Systematic Review and Meta-Analysis
- 13 July 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (11) , 3638-3647
Vasoplegic Syndrome during Left Ventricular Assist Device Insertion: A Systematic Review and Meta-Analysis
- 5 June 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (10) , 3072-3074
Pushing Boundaries: Pulsed Field Ablation as First-Line Therapy for Persistent Atrial Fibrillation and Implications for Cardiac Anesthesiologists
- 5 June 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (10) , 3072-3074
Pushing Boundaries: Pulsed Field Ablation as First-Line Therapy for Persistent Atrial Fibrillation and Implications for Cardiac Anesthesiologists
- 5 May 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
The Use of Methadone in Adult Cardiac Surgery: A Systematic Review With Narrative Synthesis
Methadone is a long-acting opioid with multifaceted analgesic properties that is under increasing investigation as an intraoperative analgesic in cardiac surgery. A systematic search of United States National Library of Medicine Database (MEDLINE) and Excerpta Medica Database (EMBASE) databases identified publications investigating the use of intraoperative methadone in adult cardiac surgical patients. The risk of bias and quality of evidence of these studies were assessed, and data from these reports were extracted and presented in a narrative format. Sixteen eligible publications were included. Although the quality of the studies was moderate to high, the certainty of the evidence is low due to the limited available data regarding optimal dosing strategies, timing of administration in relation to cardiopulmonary bypass, and long-term safety outcomes. The composite data suggest that a single dose of intraoperative methadone results in less postoperative pain and opioid consumption postoperatively without any increased risk for QTc prolongation or respiratory depression. Doses of 0.1 to 0.3 mg/kg are reported in the cardiac surgery literature; however, there is evidence of a dose–response relationship with methadone’s analgesic benefits and increased deliriogenic side effects. Studies using 0.1 mg/kg reveal equivocal analgesia, whereas the studies administering ≥0.2 mg/kg consistently report lower postoperative pain scores and opioid consumption compared to short-acting intravenous (IV) opioids. Crucially, the use of cardiopulmonary bypass significantly impacts methadone’s plasma concentrations and must be considered when determining the optimal dose and timing of administration. Further, recent observational studies offer valuable insight into methadone’s role in multimodal enhanced recovery after cardiac surgery protocols. Additional trials are needed to refine methadone usage in this population.
- 5 May 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
The Use of Methadone in Adult Cardiac Surgery: A Systematic Review With Narrative Synthesis
Methadone is a long-acting opioid with multifaceted analgesic properties that is under increasing investigation as an intraoperative analgesic in cardiac surgery. A systematic search of United States National Library of Medicine Database (MEDLINE) and Excerpta Medica Database (EMBASE) databases identified publications investigating the use of intraoperative methadone in adult cardiac surgical patients. The risk of bias and quality of evidence of these studies were assessed, and data from these reports were extracted and presented in a narrative format. Sixteen eligible publications were included. Although the quality of the studies was moderate to high, the certainty of the evidence is low due to the limited available data regarding optimal dosing strategies, timing of administration in relation to cardiopulmonary bypass, and long-term safety outcomes. The composite data suggest that a single dose of intraoperative methadone results in less postoperative pain and opioid consumption postoperatively without any increased risk for QTc prolongation or respiratory depression. Doses of 0.1 to 0.3 mg/kg are reported in the cardiac surgery literature; however, there is evidence of a dose–response relationship with methadone’s analgesic benefits and increased deliriogenic side effects. Studies using 0.1 mg/kg reveal equivocal analgesia, whereas the studies administering ≥0.2 mg/kg consistently report lower postoperative pain scores and opioid consumption compared to short-acting intravenous (IV) opioids. Crucially, the use of cardiopulmonary bypass significantly impacts methadone’s plasma concentrations and must be considered when determining the optimal dose and timing of administration. Further, recent observational studies offer valuable insight into methadone’s role in multimodal enhanced recovery after cardiac surgery protocols. Additional trials are needed to refine methadone usage in this population.
- 26 February 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (7) , 2244-2245
Standardizing Vasoplegia Management After Cardiopulmonary Bypass: Progress but Questions Remain on Defining Vasoplegia and Sequencing Therapeutics
- 26 February 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (7) , 2244-2245
Standardizing Vasoplegia Management After Cardiopulmonary Bypass: Progress but Questions Remain on Defining Vasoplegia and Sequencing Therapeutics
- 4 February 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (5) , 902-903
Reconsidering “latent” right ventricular dysfunction: The role of preoperative pulmonary artery pulsatility index in left ventricular assist device risk assessment
- 4 February 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (5) , 902-903
Reconsidering “latent” right ventricular dysfunction: The role of preoperative pulmonary artery pulsatility index in left ventricular assist device risk assessment
- 15 October 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (1) , 411-413
Moving the Goalposts: Need to Adjust for Vasoactive Inotropic Support when Interpreting Hemodynamics Effects of the Impella 5.5 in Cardiogenic Shock Patients
- 15 October 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (1) , 411-413
Moving the Goalposts: Need to Adjust for Vasoactive Inotropic Support when Interpreting Hemodynamics Effects of the Impella 5.5 in Cardiogenic Shock Patients
- 12 April 2025
- Published by SAGE Publications in Seminars in Cardiothoracic and Vascular Anesthesia
- Vol. 29 (4) , 246-257
Etomidate vs Ketamine-Propofol for Induction of Anesthesia in Coronary Artery Bypass Grafting: An Updated Systematic Review and Meta-Analysis
Background: Etomidate has minimal cardiovascular depressant effects at the cost of endogenous cortisol production suppression, whereas propofol has vasodilatory and myocardial depressant properties, which may be poorly tolerated in the cardiac surgical population. To offset the undesirable effects of propofol, ketamine can be co-administered to harness its cardiac stimulatory properties. Though etomidate is a more cardio-stable induction agent than propofol, its superiority over the combination of propofol and ketamine—colloquially known as “ketofol”—remains controversial. Methods: United States National Library of Medicine Database (MEDLINE) and Excerpta Medica Database (EMBASE) were searched for randomized controlled trials published since 2010 comparing etomidate and ketofol relative to propofol alone for induction of general anesthesia for coronary artery bypass grafting (CABG). Key data collected included post-induction nadir mean arterial pressure (MAP), heart rate, cardiac index, systemic vascular resistance (SVR), and serum cortisol levels at 24 hours postoperatively. Variables were compared by calculating a weighted mean difference (WMD) [95% confidence interval (CI)]. Results: This analysis included 15 studies (1125 patients). Anesthetic induction with etomidate was associated with a higher nadir MAP and SVR compared to ketofol during the peri-induction period by WMD 4.77 mmHg [95% CI 0.31, 9.23, P = 0.04] and 42.22 dynes/cm 5 [95% CI 0.49-83.94, P = 0.05]. However, there was no difference in the frequency of needed boluses of vasopressors or fluids for peri-induction hypotension. Conclusions: Though etomidate appears to provide a superior hemodynamic profile compared to ketofol, both agents require similar degrees of clinical response to hypotension during the induction of CABG surgery patients.
- 12 April 2025
- Published by SAGE Publications in Seminars in Cardiothoracic and Vascular Anesthesia
- Vol. 29 (4) , 246-257
Etomidate vs Ketamine-Propofol for Induction of Anesthesia in Coronary Artery Bypass Grafting: An Updated Systematic Review and Meta-Analysis
Background: Etomidate has minimal cardiovascular depressant effects at the cost of endogenous cortisol production suppression, whereas propofol has vasodilatory and myocardial depressant properties, which may be poorly tolerated in the cardiac surgical population. To offset the undesirable effects of propofol, ketamine can be co-administered to harness its cardiac stimulatory properties. Though etomidate is a more cardio-stable induction agent than propofol, its superiority over the combination of propofol and ketamine—colloquially known as “ketofol”—remains controversial. Methods: United States National Library of Medicine Database (MEDLINE) and Excerpta Medica Database (EMBASE) were searched for randomized controlled trials published since 2010 comparing etomidate and ketofol relative to propofol alone for induction of general anesthesia for coronary artery bypass grafting (CABG). Key data collected included post-induction nadir mean arterial pressure (MAP), heart rate, cardiac index, systemic vascular resistance (SVR), and serum cortisol levels at 24 hours postoperatively. Variables were compared by calculating a weighted mean difference (WMD) [95% confidence interval (CI)]. Results: This analysis included 15 studies (1125 patients). Anesthetic induction with etomidate was associated with a higher nadir MAP and SVR compared to ketofol during the peri-induction period by WMD 4.77 mmHg [95% CI 0.31, 9.23, P = 0.04] and 42.22 dynes/cm 5 [95% CI 0.49-83.94, P = 0.05]. However, there was no difference in the frequency of needed boluses of vasopressors or fluids for peri-induction hypotension. Conclusions: Though etomidate appears to provide a superior hemodynamic profile compared to ketofol, both agents require similar degrees of clinical response to hypotension during the induction of CABG surgery patients.
- 20 February 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (6) , 1610-1611
From Rescue to Prevention: Prophylactic Hydroxocobalamin Shows Promise in Mitigating Vasoplegic Shock Post Cardiopulmonary Bypass
- 20 February 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (6) , 1610-1611
From Rescue to Prevention: Prophylactic Hydroxocobalamin Shows Promise in Mitigating Vasoplegic Shock Post Cardiopulmonary Bypass